Prestige Wealth Management Group LLC Gilead Sciences, Inc. Transaction History

Prestige Wealth Management Group LLC

$456 Million
Q4 2024

A detailed history of Prestige Wealth Management Group LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 1,121 shares of GILD stock, worth $120,518. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,121

Previous 1,121 -0.0%

Holding current value

$120,518

Previous $93,000 10.75%

% of portfolio

0.02%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$63.15 - $72.88 $9,283 - $10,713	-147 Reduced 11.59%	1,121 $76,000
Q1 2024 Apr 26, 2024	SELL	$71.58 - $87.29 $16,964 - $20,687	-237 Reduced 15.75%	1,268 $92,000
Q4 2023 Apr 26, 2024	SELL	$73.27 - $83.09 $12,382 - $14,042	-169 Reduced 10.1%	1,505 $121,000
Q4 2023 Feb 08, 2024	SELL	$73.27 - $83.09 $12,382 - $14,042	-169 Reduced 10.1%	1,505 $121,000
Q3 2023 Apr 26, 2024	SELL	$73.94 - $80.67 $9,981 - $10,890	-135 Reduced 7.46%	1,674 $125,000
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $9,981 - $10,890	-135 Reduced 7.46%	1,674 $125,000
Q2 2023 Apr 26, 2024	SELL	$76.01 - $86.7 $271,051 - $309,172	-3,566 Reduced 66.34%	1,809 $139,000
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $271,051 - $309,172	-3,566 Reduced 66.34%	1,809 $139,000
Q1 2023 Apr 26, 2024	BUY	$77.31 - $88.08 $317,512 - $361,744	4,107 Added 323.9%	5,375 $445,000
Q1 2023 May 16, 2023	BUY	$77.31 - $88.08 $274,605 - $312,860	3,552 Added 194.84%	5,375 $445,000
Q4 2022 Feb 07, 2023	SELL	$62.32 - $89.47 $197,118 - $282,993	-3,163 Reduced 63.44%	1,823 $156,000
Q3 2022 Nov 01, 2022	BUY	$59.54 - $68.01 $10,300 - $11,765	173 Added 3.59%	4,986 $307,000
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $9,350 - $10,531	162 Added 3.48%	4,813 $298,000
Q1 2022 May 05, 2022	BUY	$57.92 - $72.58 $163,624 - $205,038	2,825 Added 154.71%	4,651 $276,000
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $12,976 - $14,728	-200 Reduced 9.87%	1,826 $133,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $13,538 - $14,606	-200 Reduced 8.98%	2,026 $141,000
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $7,500 - $8,557	125 Added 5.95%	2,226 $144,000
Q4 2020 Feb 17, 2021	SELL	$56.65 - $64.55 $12,123 - $13,813	-214 Reduced 9.24%	2,101 $123,000
Q3 2020 Oct 26, 2020	BUY	$62.1 - $78.08 $186 - $234	3 Added 0.13%	2,315 $146,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $9,910 - $11,508	-137 Reduced 5.59%	2,312 $177,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $42,713 - $54,710	682 Added 38.6%	2,449 $183,000
Q4 2019 Jan 28, 2020	SELL	$61.62 - $67.78 $62,729 - $69,000	-1,018 Reduced 36.55%	1,767 $115,000
Q2 2019 Aug 16, 2019	BUY	$61.87 - $69.38 $866 - $971	14 Added 0.51%	2,785 $188,000
Q1 2019 Aug 16, 2019	SELL	$62.53 - $70.05 $5,315 - $5,954	-85 Reduced 2.98%	2,771 $180,000
Q4 2018 Apr 16, 2019	BUY	$60.54 - $79.0 $172,902 - $225,624	2,856 New	2,856 $179,000

Others Institutions Holding GILD

# of Institutions

2,101

Shares Held

1.02B

Call Options Held

8.73M

Put Options Held

9.63M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $135B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.

Account

Prestige Wealth Management Group LLC Gilead Sciences, Inc. Transaction History